Close

Needham & Company Downgrades Chelsea Therapeutics (CHTP) to Hold on Pending Takeover May 9, 2014 10:17AM
Chelsea Therapeutics (CHTP) Target Lifted to $10 at Needham & Company Feb 19, 2014 07:07AM
Chelsea Therapeutics (CHTP) Target Lifted to $8 at Needham & Company on FDA AdCom Support Jan 15, 2014 07:20AM
Chelsea Therapeutics (CHTP) Prices 6.67M Common Offering at $3/Share Nov 13, 2013 08:46AM
Pre-Open Stock Movers 10/10: (ACUR) (CHTP) (NFLX) Higher; (CTXS) (RT) (CKSW) Lower (more...) Oct 10, 2013 09:29AM
View Older Stories

Feb 20, 2013 02:42PM UPDATE: Needham & Company Upgrades Chelsea Therapeutics (CHTP) to Buy
Jul 18, 2012 10:30AM Needham & Company Maintains a 'Hold' on Chelsea Therapeutics (CHTP); Need More Clarity
Mar 29, 2012 03:22PM Needham & Company Downgrades Chelsea Therapeutics (CHTP) to Hold; Receives Complete Response Letter for Northera
Mar 27, 2012 04:42PM Traders Eye Chelsea Therapeutics (CHTP) Ahead of Northera PDUFA Date
Mar 7, 2012 07:47AM Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Q4 Review: Northera PDUFA Date Approaching
Feb 24, 2012 08:27AM Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); FDA Votes in Favor of Northera
Jan 5, 2012 04:04PM Chelsea Therapeutics (CHTP) Plans to Offer $20 Million in Common Stock
Nov 3, 2011 08:50AM Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Interim CH-4051 Data in RA Consistent with Safety/Efficacy Benefits Over Methotrexate
Sep 22, 2011 02:01PM Needham & Company Maintains a 'Buy' on Chelsea Therapeutics (CHTP); Overall Undervalued
Jul 27, 2011 08:58AM Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); 2Q11 Review: Northera NDA Submission Expected Later this Quarter
May 10, 2011 07:58AM Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Q1 Review; Northera NDA Submission May Offer Upside in Q3
Apr 18, 2011 12:48PM Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Northera NDA Submission on Track for 3Q11
Jan 19, 2011 08:40AM Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Option Strategy
Dec 20, 2010 11:48AM Needham & Company reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Regulatory Timelines Accelerated, But Believe Positive Study 306 Outcome May Still Be Needed for Approval
Nov 2, 2010 08:21AM Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Droxidopa Programs Remain on Track
Sep 28, 2010 04:02PM Chelsea Therapeutics (CHTP) Announces $35M Common Offering
Sep 21, 2010 07:55AM Needham & Company reiterates a 'Buy' rating on Chelsea Therapeutics (CHTP); Droxidopa Study 301 Meets Primary Endpoint
Sep 20, 2010 04:44PM Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Droxidopa Study 301 Meets Primary Endpoint, an Important Milestone
Aug 10, 2010 01:34PM Unusual 11 Mid-Day Movers 08/10: RMX, AAU, ZSTN, HOOK, QNST, CHTP Higher; CYRX, SCLN, HQS, ABK, CVBF Lower
Apr 30, 2010 02:14PM Needham & Company reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Droxidopa Program Remains on Track, Shares Undervalued
Mar 23, 2010 09:01AM Needham & Company Initiates Coverage on Chelsea Therapeutics (CHTP) with a Buy
Mar 23, 2010 07:28AM Needham & Company Initiates Coverage of Chelsea Therapeutics (CHTP) with a Buy
Mar 22, 2010 05:18PM Needham Starts Chelsea Therapeutics (CHTP) at Buy with $7 Price Target
Feb 26, 2010 09:00AM Chelsea Therapeutics (CHTP) to Raise $18.2M in Offering of Stock and Warrants
View Older Stories